Table 3.
Lipid profile of the overweight/obese study participants after 12 weeks Nitraria retusa intake compared to placebo group.
| Variables (Units) |
Placebo Group a (n = 13) |
NRE Group a (n = 30) |
Between Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | After 12 Weeks | Δ b | p-Value c | Baseline | After 12 Weeks | Δ b | p-Value c | Δ d | p Value e | Adjusted p-Value f | |
| Lipid profile | |||||||||||
| HDL, mmol/L | 1.17 (0.096) |
1.228 (0.06) |
+0.057 (0.07) |
0.224 | 1.22 (0.04) |
1.29 (0.046) |
+0.07 (0.02) |
0.007 | 0.013 (0.05) |
0.778 | 0.985 |
| TG, mmol/L | 1.056 (0.081) |
1.19 (0.111) |
+0.13 (0.07) |
0.095 | 1.32 (0.11) |
1.19 (0.13) |
−0.127 (0.056) |
0.022 | −0.257 (0.014) |
0.011 | 0.016 |
| LDL, mmol/L | 3.30 (0.211) |
3.29 (0.17) |
−0.006 (0.16) |
0.968 | 3.28 (0.12) |
3.25 (0.14) |
−0.027 (0.10) |
0.805 | −0.021 (0.06) |
0.92 | 0.875 |
| TC, mmol/L | 4.93 (0.260) |
5.03 (0.197) |
+0.09 (0.20) |
0.648 | 5.11 (0.182) |
5.12 (0.19) |
+0.1 (0.09) |
0.902 | 0.01 (0.11) |
0.68 | 0.558 |
a Data are expressed as the mean (SD). b Mean difference at baseline and after 12 weeks of intake (12 weeks − baseline). c Within-group differences before and after intervention were compared using a paired t-test (parametric) and a Wilcoxon Signed Ranks test (nonparametric). d Mean difference between groups (NRE vs. Placebo) at 12 weeks. e Mean difference at 12 weeks was compared between groups by independent samples t-tests (parametric and equal variances), Welch’s t-test (unequal variances), and Mann–Whitney U test (nonparametric). f Adjusted p-value was calculated using ANCOVA, or Quade’s nonparametric ANCOVA, adjusted for age.